Loop diuretic — inhibits Na+/K+/2Cl- cotransporter (NKCC2) in thick ascending limb of loop of Henle. Most potent class of diuretic; cornerstone of CHF / pulmonary edema management. Ototoxicity at high IV bolus doses.
Half-Life & Elimination Curve (PO: 48m · IV: 48m)
Plasma (PO)t½ Decay (48m)
0×t½0h100%(0.54 mg/L)
1×t½48m50%(0.27 mg/L)
2×t½1.6h25%(0.135 mg/L)
3×t½2.4h12.5%(67.4 µg/L)
4×t½3.2h6.3%(33.7 µg/L)
5×t½4h3.1%(16.9 µg/L)
Elimination t½48m (PO)
Rate Constant (ke)0.866 h⁻¹
Time to Peak (Tmax)52m
Est. Peak (Cmax)0.54 mg/L
Clearance (CL)12.1 L/h
97% Washout (5×t½)4h
Dosing Guidelines
Oral (PO): Typical 40 mg (Range: 20–80 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 40% · Volume of Distribution (Vd): 14 L · Absorption (ka): 1.5 h⁻¹ (t½ka ≈ 28m) [PMID 3370062]
Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 14 L [PMID 3370062]